First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial

by Poh, Xuan Ying, Lee, I. Russel, Tan, Chee Wah, Chavatte, Jean-Marc, Fong, Siew Wai, Goh, Yun Shan, Rouers, Angeline, Wong, Nathan, Torres-Ruesta, Anthony, Mah, Shirley Y. Y., Yeoh, Aileen Y. Y., Gandhi, Mihir, Rahman, Nabilah, Chin, Yi Qing, Lim, J Jonathan, Yoong, Terence J. K., Rao, Suma, Chia, Po Ying, Ong, Sean W. X., Lee, Tau Hong, Sadarangani, Sapna P., Lin, Ray J. H., Lim, Daniel R. X., Chia, Wanni, Renia, Laurent, Ren, Ee Chee, Lin, Raymond T. P., Lye, David C., Wang, Lin-Fa, Ng, Lisa F. P., Young, Barnaby Edward
Published 2024